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Abstract
We analyse two models describing disease transmission and control on regular and small-world networks. We use
simulations to find a control strategy that minimizes the total cost of an outbreak, thus balancing the costs of disease
against that of the preventive treatment. The models are similar in their epidemiological part, but differ in how the
removed/recovered individuals are treated. The differences in models affect choice of the strategy only for very cheap
treatment and slow spreading disease. However for the combinations of parameters that are important from the
epidemiological perspective (high infectiousness and expensive treatment) the models give similar results. Moreover, even
where the choice of the strategy is different, the total cost spent on controlling the epidemic is very similar for both models.
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Introduction
Networks can provide a good representation of how individuals
interact [1–3]. Despite many simplifications, models based upon
network structures have successfully been used in many applica-
tions [4,5] including spread of rumours and news [3] and
computer viruses [1]. A particularly important application of
network models has been in epidemiology [6–10] of plant, animal
and human pathogens [11–13]. Modelling in epidemiology plays
an important role: It allows us to estimate the scale of the
epidemic, to predict how far the disease could spread and to design
effective ways of control. All these tasks need to be achieved
despite the fact that in many cases we are not able to observe the
whole process and/or measure all relevant parameters [14]. The
state of individuals, whether they are susceptible, infected and pre-
symptomatic, infected and symptomatic or recovered, is in
particular often difficult to ascertain [15]. Despite these uncer-
tainties it is possible to use modelling to design effective control
measures leading to the lowest overall cost of the epidemic
outbreak [16–19] and a number of studies have used network
models to address this issue [14,20–23].
Economic and behavioural aspects influence the spread of
disease and affect the choice of a control strategy. For instance, if
the treatment does not cost anything, the best strategy is to control
the whole population. Contrarily, for very expensive control
measures it might be better to refrain from treatment at all.
Optimisation of total disease costs, including palliative cost
associated with disease cases and cost of appropriate control
measures, leads to appearance of three basic strategies [20]: The
Global Strategy (GS) whereby all individuals are treated regardless
of their status can be contrasted with the Null Strategy (NS) when
the public authorities completely refrain from preventive treat-
ment and concentrate on palliative treatment of cases. The Local
Strategy (LS) emerges for intermediate costs of treatment. In this
case, not only detected symptomatic individuals are treated
preventively, but the treatment includes also their neighbours.
The work so far has concentrated on the role of processes
associated with disease spread on the broad choice of the
treatment strategy [20] and on the details of the local strategy
[21]. However, the spontaneous recovery also may affect the
results and in the current paper we explore this dependence in
detail.
We extend our results to two contrasting and yet complemen-
tary models in which we either treat individuals that have been
through the disease or not. Whether the removed individuals (i.e.
those who have been through the disease but then spontaneously
recover or die) are part of the treatment plan depends on the type
of the disease agent. The key factor in choosing the right model is
whether it is possible – and desirable – to distinguish such
individuals from those who are susceptible. If the removed class is
identified with dead individuals, the distinction is very clear.
However, if the removal means recovery and immunity, it might
not be possible to identify those who are immune. For example,
many people might not want to report that they have been
through the infection, or the disease symptoms might be relatively
mild. For animal diseases, immunological testing might be the only
way to identify such individuals, but this leads to increased costs
and test results might not be reliable. In other situations, we might
know the status of the individual, but might not be able to target
the treatment to susceptible and infected individuals. Plant and
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crop diseases might serve as an example here, whereby it might be
easier to treat the whole field regardless of whether some plants
there are already immune to the disease.
Although such individuals do not contribute to the spread of the
disease, the cost of treating them affects the economic side of the
evaluation and therefore leads to changes in the design of the
optimal strategy. We study this case in our paper and show that
although there is a difference in the choice of the strategy (LS vs.
GS) and the resulting number of treated individuals, there is only a
small difference in the overall total cost of the epidemic.
Methods
We assume that individuals are located at nodes of a square
lattice that represents geographical distribution of hosts, see fig. 1.
On this lattice, we define a local infection neighbourhood of order
zinf as a von Neumann neighbourhood. In that neighbourhood
2zinf (zinf z1)z1 individuals are included, involving the central
one. We additionally define z~0 as corresponding to this central
individual, which means that this individual is not in contact with
anyone, while z~? corresponds to the whole population, see
fig. 1. To increase realism of our analysis, we also consider the
small-world model [24,25] which adds a certain number of links
among randomly chosen nodes, thus adding some long-range
connections to the regular lattice ones [24]. Although the disease
can spread along these long-range links, we assume that they are
so difficult to identify that they are not included in any treatment
strategy (see below).
The epidemiological SIDRV model is a standard SIR
(Susceptible-Infected-Removed) model [26], modified to account
for latent period and preventive and responsive treatment (fig. 2),
see also [21]. Taking into consideration the latent period, the
infectious class is now composed of two separate, pre-symptomatic
and symptomatic classes (S, I, D, R and V, respectively). Number
of individuals in each class is denoted by S, I , D, R, and V ,
respectively, and N~SzIzDzRzV is the total constant
number of individuals in the population.
Initially, all individuals are assumed to be susceptible (S). The
epidemic is initiated by an introduction of few infected but pre-
symptomatic (I) individuals, which are located randomly and
uniformly over the whole network. Each infected individual is in
contact with a fixed number of other individuals in its infection
neighbourhood zinf . These connections do not change during the
epidemic. The disease is transmitted along these contact routes
with probability f per contact. Upon a successful infection, the
susceptible individual moves to the pre-symptomatic class.
Each infected pre-symptomatic individual moves to a symp-
tomatic class (D) with probability q. Detected individuals still can
infect other individuals. Subsequently, each detected individual
can spontaneously move to a removed class (R) with probability r.
However, detection also triggers a control event with probability v
and subsequently a number of individuals selected from the von
Neumann neighbourhood of order z centered at the detected
individual move to a treated class (V); for details see below. Neither
R nor V can infect or be re-infected any more.
According to the responsive treatment two versions of the
SIDRV model have considered: (i) model 1 with control of all
individuals in selected area except removed (R class), see fig. 1b,
Figure 1. (a) Definition of the von Neumann neighborhood of
different values of order z, as used in the simulations and
analysis. (b) Illustration of spread of a disease (model 1) on a regular
network with additional randomly chosen long-range links represented
by curved lines (approximation of a small-world network). The applied
control of radius z is centered on node D (yellow shaded area). Note
that in model 1 the R individuals are excluded from the control and
thus non-treated. (c) Representation of model 2: All individuals
contained in the control neighbourhood of order z are preventively
treated and moved to V class. In both models treatment does not take
into account individuals connected by additional long-range links. S, I,
D, R symbols stand for Susceptible, Pre-symptomatic, Symptomatic and
Recovered, respectively. The order z of infection neighbourhood equals
zinf ~2 in (b) and (c).
doi:10.1371/journal.pone.0063813.g001
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and (ii) model 2 with control of all individuals in selected area
regardless of their status (and thus including R), see fig. 1c.
The control event is localized within a von Neumann
neighbourhood of order z centred on a symptomatic individual.
The order of control neighbourhood, z, can be different than the
order of the infection neighbourhood, zinf , and is typically found
larger. Thus, a group of individuals in the treatment neighbour-
hood consists of a mixture of susceptible, infected pre-symptom-
atic, infected symptomatic and recovered individuals (preventive
treatment). We have extended the definition of control neighbor-
hood size in order to include the situation when no control is
applied, z~{1.
Simulations
All simulations have been performed on the lattice of 200 by
200 individuals with periodic boundary conditions. Simulations
started with 40 initial infected foci, which corresponds to 0:1% of
the total population.
Control size, z, has been varied, while other parameters (such as
f , q, v, r, zinf ,) have been kept constant. Each simulation has been
run until I(t)zD(t)~0, which means that no infection can occur
afterwards. At the end of the run all R and V individuals have
been counted, yielding information about severity of the epidemic
as well as effectiveness of the treatment involved.
Effectiveness of control strategies
The effective control strategy is found by taking into account
severity of the epidemic and its financial implications. In order to
quantify the effectiveness of different control strategies we
introduce the severity index, X [15,20]. By seeking the minimum
values of X , we find which strategy is optimal.
The severity index, X , includes two terms corresponding to the
cost of infection and control. First term describes costs associated
with death, absence in work, lower productivity etc., whereas
second term includes costs of vaccine, quarantine, transport of
drugs to infection foci, etc. We assume that X is a linear
combination of number of individuals which have gone through
disease and recovered (R) and treated individuals (V).
We measure X in units of a number of single infected
individuals, so that:
X (z,t~?)~R(z,t~?)zcV (z,t~?) : ð1Þ
Here c represents a cost of treatment relative to the cost of
infection and z stands for the control neighbourhood size. Both
R(z,t~?) and V (z,t~?) are counted at the end of a single
simulation run.
Effective strategy is equivalent to the minimal value of X , which
means that the epidemic is stopped at the manageable cost. In our
simulation, the minimization of the severity index has been
achieved by sweeping through different values of control
neighbourhood size, z while keeping other parameters constant.
Once z is set, we let the system evolve and then compute the value
of X in the stationary state. We repeat this operation 100 times
and then we denote with zc and Xc the average values, of z and X ,
corresponding to the minimum of X , so that
min
{1ƒzƒ50
X (z,t~?)~Xc(zc,t~?) : ð2Þ
Results
In the absence of control, the disease will either progress
through the population until it exhausts a large part of initially
susceptible population (for large values of the infection probability
f ) or it will quickly stop spreading (for small values of f ). As control
is applied in extended neighbourhood of radius zc centred at a
symptomatic individual, the number of recovered (R) individuals
declines rapidly, see fig. 3a. Models 1 and 2 examined in this work
differ in the way they treat or not treat the recovered class, R, cf
fig. 1 We observe the same behaviour for both considered models
(with and without treating R class). However, when we allow the
control of R individuals (model 2), the proportion of recovered
declines faster than in model 2, see fig. 3a (insert). The proportion
of preventively treated individuals, V, in both models is similar for
the whole range of control size, z. With increasing control
neighbourhood, V(z) grows very quickly, then drops near z~6 and
finally rises monotonically till z*50 (fig. 3b). Combination of these
two relationships, R(z) and V (z), according to eq(1), gives total
Figure 2. Model scheme of disease transition (black lines) and control (orange lines). In model 2 there is a possible transition between
recovered (R) and treated (V) class when R-individual is in the control neighbourhood of any symptomatic D-individual.
doi:10.1371/journal.pone.0063813.g002
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cost of epidemic, X , as a function of z, see fig. 3c. For a very low
treatment cost, e.g. c~0:0003, total cost of control of epidemic, X ,
is almost equal for both models, with difference less than 0:1%, see
fig. 3c (insert). The choice of optimal strategies is different for
model 1 (GS) than for model 2 (LS), although the corresponding X
values are similar. In model 1 the minimal value of X corresponds
to the highest value of control size, zc~50 (GS), whereas in model
2, the minimum is identified with zc~6, (LS) fig. 3c.
Regular networks – influence of recovery rate, r on control
strategies
Increasing cost of treatment, c, decreases the optimal control
neighbourhood, zc. For very cheap control the optimal scenario is
identified with zc*45 (GS) for model 1, regardless of the recovery
rate, r (fig. 4a). The more expensive the treatment, the higher the
total costs spent on controlling outbreaks. This leads to change in
optimal strategy, see fig. 4a, b. We cannot afford the preventive
control of the whole population (GS) and have to shift into treating
in neighbourhood of symptomatic individuals. We observe that zc
rapidly decreases with increasing costs, especially for model 1. For
intermediate values of c, zc drops to *10 depending on recovery
rate, r. Higher recovery rate, r, results not only in a shorter
plateaux for LS (see fig. 4a, b) but also moves the plateaux towards
larger control size, zc. As treatment becomes more expensive,
second threshold is observed that describes change from LS to NS.
Although for model 2 the global strategy is selected rather than the
local one as for model 1 (fig. 4b, d) for the high values of recovery
rate, r and low c, the total cost of epidemic, Xc, does not differ
much between the two models, see fig. 5. The highest costs are
associated with fast spreading diseases (large f ) and expensive
treatment (large c) for both models (upper right part of plots in
fig. 5). Slow spreading disease does not significantly affect the
budget for control regardless of treatment costs (lower part of plots
in fig. 5) and model selected. For model 2 the global strategy is
predominantly selected for high values of recovery rate r and at
low c, in contrast to model 1 (fig. 4b, d) where the local strategy
prevails. Despite these differences, the total cost of epidemic, Xc,
does not differ between the two models, see fig. 5.
Regular networks – control strategies
Control size, zc depends strongly on the cost of treatment, c,
and on the infectiousness of the disease, f (fig. 6). For small f and
c, both models suggest preventive control extended to the whole
population (GS) (lower left part of each plot in fig. 6). In case of
highly infectious disease and low treatment costs, model 1 predicts
higher effectiveness of GS whereas model 2 selects LS as an
optimal solution, upper left part of each plot in fig. 6. However, in
both examined models the total cost of epidemic, X, is
approximately the same, see fig. 3. As treatment cost, c, increases,
LS becomes the most cost-effective strategy. LS changes to NS
when c is of order 1 for small f and of order 10 for high f ,
regardless of the choice of the model or the exact value of r,
compare fig. 6a, b with fig. 6c, d.
The main difference in selection of the optimal strategy occurs
for small c. Changes in r affect only low c regions. Increasing r
from 0:1 to 0:2 extends the region of validity of GS and moves it
towards marginally larger values of c and high values of f , fig. 6c,











R(z), without control R


















V(z), without control R



















X(z), without control R






 0  10  20  30  40  50
c)
Figure 3. (a) The proportion of recovered individuals, R=N , (b)
the fraction of treated (controlled) individuals, V=N and (c) the
total cost of epidemic as a fraction of the system size, X=N , for
c~0:0003 and various control sizes z. Red solid line: model 1; blue
dotted line: model 2. Results of simulations with parameters f ~0:5,
q~0:5, r~0:1, v~0:1 and zinf ~1 performed on regular networks.
Inserts show the relevant magnifications of the graph.
doi:10.1371/journal.pone.0063813.g003
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be associated with faster removal of individuals without triggering
control events.
Small world networks – control strategies
Addition of small-world links does not change the behaviour for
small f and c. However, there are substantial differences for large
f and the effect differs for the two models. Introducing disorder
into the topology by adding long-range links changes ranges of
optimal strategy for both considered models, compare fig. 6a, b
with fig. 7. In model 1 small number of links, e.g.6%, fig. 7a,
extends GS when disease spreads fast and costs are higher. The
small number of links 6% in model 2 does not change choice of
control strategy, compare fig. 6b with fig. 7b, as in model 1 (top
panel in fig. 7). Nonetheless, the total cost of epidemic remains
almost the same. For large values of f , destroying spatial structure
by adding 20% links results in only two effective strategies for
highly infectious disease, GS for cv1 and NS otherwise, fig. 7c.
The higher disorder (20% of long range links) in model 2,
introduces GS when probability of spreading the epidemic, f ,
increases, fig. 7d.
Discussion
The goal in designing cost-effective control strategy is to stop the
epidemic outbreak very quickly at a minimal possible cost. In
order to achieve this by using the local strategy (LS) we need to
catch in the preventive control neighbourhood as many infected
but pre-symptomatic individuals and to form a fire-break by
treating around the infection focus. The extend of control is a
crucial factor; however, it is not obvious by how much we need to
enlarge the neighborhood in which preventive treatment is
applied. We need to balance epidemiological and economic
aspects of disease spread and control [27]. When we extend
prevention to the whole population we might be able to
successfully protect population from epidemic outbreaks but we
will need to spend a lot of resources. On the other hand, when we
apply control to too small neighbourhood, we will spend a lot but
the disease will still invade the whole population. Under some
conditions an optimal solution emerges in between these two
extremes and can be associated with the Local Strategy; in other
cases the extreme solutions (Global Strategy and Null Strategy) are
optimal. As we have already shown [20,21], the effective control
neighbourhood can be chosen based on combined epidemiological
and economic analysis.
The previous analyses [20,21] left three key questions unan-
swered. Firstly, should we treat individuals that are already
immune? Although the answer clearly depends on the nature of
the disease and the treatment, some general principles can be
established. This depends on the relative – economic, social and
medical – cost of the preventive treatment compared to the
palliative care (when we just let the disease to run its natural
course). Secondly, are our results stable with respect to structural
changes of the model? We illustrate the stability by considering
two versions of the same model, with and without treating
recovered R individuals. Finally, it is the dependence of the results
on the actual recovery rate, r. In real-life applications it is difficult
to distinguish between individuals that have been through the
disease and those who do not. It is therefore very important to
check whether the model and the resulting policy implications are
robust with respect to the potential uncertainties. We show that
this is the case in general but also identify the region of the
parameters when the two models have different behavior (small c,
large f ).
Figure 4. Control size zc as a function of the treatment cost c ((a) and (b)) and as a function of the recovery rate, r, and the treatment
cost, c ((c) and (d)) for model 1 (left column) and model 2 (right column). In (a) and (b) r~0:10 (red line), r~0:63 (green dashed line), r~0:98
(blue dotted line). All simulations done on regular networks with parameters f ~0:1, q~0:5, v~0:1, zinf ~1.
doi:10.1371/journal.pone.0063813.g004
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Figure 5. Total cost of epidemic at optimum, Xc, as a function of the treatment cost c ((a) and (b)) and as a function of both
infectiousnes, f , and cost, c ((c) and (d)) for model 1 (left column) and model 2 (right column). In (a) and (b) f ~0:001 (red line), f ~0:032
(green dashed line), f ~0:1 (blue dotted line). All simulations done with parameters q~0:5, v~0:1, r~0:1, zinf ~1. Disease spreading on regular
networks.
doi:10.1371/journal.pone.0063813.g005
Figure 6. Control size, zc, as a function of both infectiousness, f , and treatment cost, c, for model 1 (left column) and model 2 (right
column). Simulation parameters for top panel ((a) and (b)): r~0:1; for bottom panel ((c) and (d)): r~0:2; other parameters: q~0:5, v~0:1, I(0)~40,
zinf ~1. Disease spreading on regular networks.
doi:10.1371/journal.pone.0063813.g006
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Two contrasting cases can be distinguished in answer to the first
question. If the treatment is costly and/or may lead to
complications, the authorities might want to invest in testing
individuals in order to find out who is and who is not naturally
immune. This would identify individuals in the R class who then
might not be offered the treatment. Contrariwise, if it is not
immediately obvious what the actual status of the individual is and
testing is expensive, lengthy or unreliable, the authorities might
decide to treat all individuals regardless of their status. Our results
from this paper suggest that the choice of the strategy depends on
whether treatment includes or excludes R but the total budget
spent on controlling epidemic remains similar for both models.
Secondly, in the most important region of parameter space,
corresponding to expensive preventive treatment and a highly
infectious disease, both models yield very similar scenarios (right
part of fig. 4c, d). Thus, the results appear to be stable with respect
to structural changes of the model. Where the difference is
marked, for low c and high f , the models suggest a different choice
of strategy (GS for model 1 and LS for model 2). However, we also
found that in this case the economic outcome of either GS or LS is
very similar (see fig. 3c).
Thirdly, the main effect of increasing r is to shift the boundary
between the GS and LS for small c, rendering the GS less
attractive as r decreases – and the infectious period increases. For
model 2 (without treatment of R) the area of preference of GS over
LS is limited to very small values of c. Thus, the longer the
infectious period, the more likely the local strategy is to work. The
boundary between LS and NS for large values of c remains
unchanged.
Addition of long-range links enlarges the region of applicability
of GS towards higher f and c for both models. The large number
of randomly placed long-range links destroys spatial structure of
spreading the pathogen and causes that it spreads mostly globally
so that LS is no longer effective option of control the epidemic.
The results obtained in this paper can be used for those diseases
for which spread is dominated by local transmission or by a
mixture of local and long-range links. Examples include human
(notably SARS [28] and influenza [29–31]), animal (foot-and-
mouth disease [32]) and plant diseases (citrus canker [33], sudden
oak death [34–36] and rhizomania of sugar beet [37,38]).
Although our model assumes a simple network structure, we
believe that the results can be generalised to more complex, but
also more realistic networks, including social networks [31]. This
work can also be extended in several ways. The most interesting
will be the SIRS model, in which after some period of immunity to
the disease individuals become susceptible again and could catch a
disease few times; with influenza [29–31] and sexually-transmitted
diseases [39,40] being the best examples.
Author Contributions
Conceived and designed the experiments: KO AK. Performed the
experiments: KO. Analyzed the data: KO EGN AK. Contributed
reagents/materials/analysis tools: KO EGN AK. Wrote the paper: KO
EGN AK.
References
1. Newman M (2003) The structure and function of complex networks. SIAM
Review 45: 167–256.
2. Keeling MJ, Rohani P (2007) Modeling Infectious Diseases in Humans and
Animals. Princeton University Press, 408 p.
3. Newman M (2010) Networks: An introduction. Oxford Univ Press.
4. Aleksiejuk A, Hołyst J, Stauffer D (2002) Ferromagnetic phase transition in
Barabási-Albert networks. Physica A: Statistical Mechanics and its Applications
310: 260–266.
5. Bianconi G, Barabási A (2001) Bose-Einstein condensation in complex networks.
Physical Review Letters 86: 5632–5635.
Figure 7. Control size, zc as a function of both infectiousness, f , and treatment cost, c, for model 1 (left column) and model 2 (right
column). Number of additional links with respect to all the ones that can be added, on the top panel ((a) and (b)): 6%, on the bottom panel ((c) and
(d)) –20%. Other simulation parameters: q~0:5, r~0:1, v~0:1, zinf ~1. Disease spreading on small-world networks.
doi:10.1371/journal.pone.0063813.g007
Efficient Control of Epidemics
PLOS ONE | www.plosone.org 7 June 2013 | Volume 8 | Issue 6 | e63813
6. Andersson H (1999) Epidemic models and social networks. Mathematical
Scientist 24: 128–147.
7. Keeling M, Eames K (2005) Networks and epidemic models. Journal of the
Royal Society Interface 2: 295–307.
8. Pastor-Satorras R, Vespignani A (2001) Epidemic spreading in scale-free
networks. Physical review letters 86: 3200–3203.
9. Moreno Y, Pastor-Satorras R, Vespignani A (2002) Epidemic outbreaks in
complex heterogeneous networks. The European Physical Journal B-Condensed
Matter and Complex Systems 26: 521–529.
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20. Kleczkowski A, Oleś K, Gudowska-Nowak E, Gilligan C (2012) Searching for
the most cost-effective strategy for controlling epidemics spreading on regular
and small-world networks. Journal of The Royal Society Interface 9: 158–169.
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